• Please log in or register to access this feature.

Cancer Cell Biology

You have full text access to this OnlineOpen article

Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1

  1. Benjamin D. Hedley1,2,
  2. Danny R. Welch3,
  3. Alison L. Allan1,4,5,
  4. Waleed Al-Katib1,
  5. David W. Dales1,
  6. Carl O. Postenka1,
  7. Graham Casey6,
  8. Ian C. MacDonald2,4,
  9. Ann F. Chambers1,2,4,7,†,*

Article first published online: 9 MAY 2008

DOI: 10.1002/ijc.23542

Issue

International Journal of Cancer

International Journal of Cancer

Volume 123, Issue 3, pages 526–534, 1 August 2008

Additional Information

How to Cite

Hedley, B. D., Welch, D. R., Allan, A. L., Al-Katib, W., Dales, D. W., Postenka, C. O., Casey, G., MacDonald, I. C. and Chambers, A. F. (2008), Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. Int. J. Cancer, 123: 526–534. doi: 10.1002/ijc.23542

Author Information

  1. 1

    London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada

  2. 2

    Department of Medical Biophysics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada

  3. 3

    Department of Pathology and Comprehensive Cancer Centre, University of Alabama at Birmingham, Birmingham, AL

  4. 4

    Department of Oncology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada

  5. 5

    Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada

  6. 6

    Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH

  7. 7

    Department of Pathology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada

  1. †

    Fax: +1-519-685-8646.

*London Regional Cancer Program, London Health Sciences Centre, 790 Commissioners Road East, London, Ontario, N6A 4L6 Canada

  1. †

    Fax: +1-519-685-8646.

Publication History

  1. Issue published online: 28 MAY 2008
  2. Article first published online: 9 MAY 2008
  3. Manuscript Accepted: 24 JAN 2008
  4. Manuscript Received: 28 AUG 2007

Funded by

  • Canadian Institutes of Health Research. Grant Number: 42511
  • Ontario Cancer Research Network. Grant Number: 04MAY00089
  • U.S P.H.S. Grant Number: CA87728
  • U.S. Army Medical Research and Materiel Command. Grant Number: DAMD17-2-01-0541

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (1310K)

This article contains supplementary material available via the internet at http://www.interscience.wiley.com/jpages/0020-7136/suppmat .

FilenameFormatSizeDescription
ijc23542-Sup_Table1.doc43KSupporting Information file ijc23542-Sup_Table1.doc
ijc23542-SupFig1.eps20236KSupporting Information file ijc23542-SupFig1.eps
ijc23542-SupFig2.eps20170KSupporting Information file ijc23542-SupFig2.eps
ijc23542-SupFig3.eps8416KSupporting Information file ijc23542-SupFig3.eps

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

View Full Article with Supporting Information (HTML) Get PDF (1310K)